Senti Biosciences
Senti Biosciences is a biotechnology company focused on synthetic biology and gene circuit engineering for therapeutic applications. Senti Bio utilizes a synthetic biology platform named Gene Circuits to develop therapies that offer improved precision and control. These circuits are engineered to selectively eliminate cancer cells while sparing healthy ones, enhancing specificity for target cells, and regulating drug expression post-administration. Senti's Gene Circuits have been demonstrated in preclinical studies to be effective in both NK and T cells. Additionally, Senti Bio has shown in preclinical research the potential applicability of Gene Circuits in a variety of other treatment areas and diseases beyond oncology, and is actively progressing these efforts through partnerships.
Domain
sentibio.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$1.0M
Founded
2015
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does Senti Biosciences use?+
Senti Biosciences uses 19 technologies including Google Analytics, Google Tag Manager, Modernizr.
What industry is Senti Biosciences in?+
Senti Biosciences operates in the Biotechnology industry.
Where is Senti Biosciences based?+
Senti Biosciences is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026